Chemoenzymatic synthesis and some biological properties of O-phosphoryl derivatives of (E)-resveratrol

Natural Product Communications

Volumn 3, Issue 10, 2008, Pages 1693-1700

  Aleo, Danilo ^a   Cardile, Venera ^a   Chillemi, Rosa ^a   Granata, Giuseppe ^b   Sciuto, Sebastiano ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b CNR   (Italy)

Author keywords

Antiproliferative activity; DNA interaction; Enzymatic acylation; Phosphorylation; Resveratrol derivatives

Indexed keywords

3 O PHOSPHORYLRESVERATROL; 3,5 DI O PHOSPHORYLRESVERATROL; 4' O PHOSPHORYLRESVERATROL; ORGANIC SOLVENT; PHOSPHORAMIDOUS ACID; RESVERATROL; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ACYLATION; ARTICLE; BINDING AFFINITY; BURKHOLDERIA CEPACIA; CANCER CELL; CANDIDA ANTARCTICA; CYTOTOXICITY; DRUG DNA INTERACTION; HUMAN; HUMAN CELL; MALE; PHOSPHORYLATION; PROSTATE CANCER; ULTRAVIOLET SPECTROSCOPY;

CANDIDA ANTARCTICA; PSEUDOMONAS;

EID: 77954136382     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x0800301023     Document Type: Article

References (23)

1. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CWW, Fong HHS, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 275, 218-220.
2. Gehm BD, McAndrews JM, Chien P-Y, Jameson JL. (1997) Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proceedings of the National Academy of Sciences USA, 94, 14138-14143.
3. Soleas GJ, Diamandis EP, Goldberg DM. (1997) Resveratrol: a molecule whose time has come? And gone?. Clinical Biochemistry, 30, 91-113.
4. (a) Frémont L. (2000) Biological effects of resveratrol. Life Sciences, 66, 663-673;
5. (b) Chillemi R, Sciuto S, Spatafora C, Tringali C. (2006) Anti-tumor properties of stilbene-based resrveratrol analogues: Recent results, Natural Product Communications, 2, 499-513.
6. Bhat KPL, Kosmeder JW II, Pezzuto JM. (2001) Biological effects of resveratrol. Antioxidants & Redox Signaling, 3, 1041-1064.
7. Learmonth DA. (2003) A concise synthesis of the 3-O-β-D- and 4′-O-β-D-glucuronide conjugates of trans-resveratrol. Bioconjugate Chemistry, 14, 262-267.
8. Orsini F, Pelizzoni F, Verotta L, Aburjai T. (1997) Isolation, synthesis and antiplatelet aggregation activity of resveratrol 3-O-β-Dglucopyranoside and related compounds. Journal of Natural Products, 60, 1082-1087.
9. Declercq L, Corstjens H, Maes D, Van Brussel W, Schelkens G. (2006) Topical compositions containing phosphorylated polyphenols. WO 2006029484.
10. Usha S, Johnson IM, Malathi R. (2005) Interaction of resveratrol and genistein with nucleic acids. Journal of Biochemistry and Molecular Biology, 38, 198-205.
11. Usha S, Johnson IM, Malathi R. (2006) Modulation of DNA intercalation by resveratrol and genistein. Molecular and Cellular Biochemistry, 284, 57-64. (Pubitemid 44404410)
12. Hadimani MB, Hua J, Jonklaas MD, Kessler RJ, Sheng Y, Olivares A, Tanpure RP, Weiser A, Zhang J, Edvardsen K, Kane RR, Pinney KG. (2003) Synthesis, in vitro and in vivo evaluation of phosphate ester derivatives of combretastatin A-4. Bioorganic & Medicinal Chemistry Letters, 13, 1505-1508.
13. Pettit GR, Grealish MP, Herald DL, Boyd MR, Hamel E, Pettit RK. (2000) Antineoplastic agents. 443. Synthesis of the cancer cell growth inhibitor hydroxyphenstatin and its sodium diphosphate prodrug. Journal of Medicinal Chemistry, 43, 2731-2737. (Pubitemid 30463921)
14. Pettit GR, Grealish MP, Jung MK, Hamel E, Pettit RK, Chapuis JC, Schmidt JM. (2002) Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphate. Journal of Medicinal Chemistry, 45, 2534-2542. (Pubitemid 34595223)
15. Nicolosi G, Spatafora C, Tringali C. (2002) Chemo-enzymatic preparation of resveratrol derivatives. Journal of Molecular Catalysis. B: Enzymatic, 16, 223-229.
16. Ratan HL, Steward WP, Gesher AJ, Mellon JK. (2002) Resveratrol-A prostate cancer chemopreventive agent? Urologic Oncology, 7, 223-227. (Pubitemid 36026527)
17. Hsieh TC, Wu JM. (1999) Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Experimental Cell Research, 249, 109-115.
18. Morris GZ, Williams RL, Elliot MS, Beebe SJ. (2002) Resveratrol induces apoptosis in LNCaP cells and requires hydroxyl groups to decrease viability in LNCaP and DU 145 cells. Prostate, 52, 319-329.
19. Cardile V, Lombardo L, Spatafora C, Tringali C. (2005) Chemo-enzymatic synthesis and cell-growth inhibition activity of resveratrol analogues. Bioorganic Chemistry, 33, 22-33. (Pubitemid 40164184)
20. Stivala LA, Savio M, Carafoli F, Perucca P, Bianchi L, Maga G, Forti L, Pagnoni UM, Albini A, Prosperi E, Vannini V. (2001) Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. Journal of Biological Chemistry, 276, 22586-22594.
21. Jayatilake GS, Baker BJ, McClintock JB. (1995) Isolation and identification of a stilbene derivative from the Antarctic sponge Kirkpatrickia variolosa. Journal of Natural Products, 58, 1958-1960.
22. Mosmann T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65, 55-63.
23. Ahmad A, Asad SF, Singh S, Hadi SM. (2000) DNA breakage by resveratrol and Cu(II): reaction mechanism and bacteriophage inactivation. Cancer Letter, 154, 29-37.